ClinicalTrials.gov
public full text
Public Domain
Botulinum Toxin in the Management of Temporo-mandibular Related Myalgia: a Prospective Study
The aim of this study was to evaluate the clinical course in terms of pain, function and quality of life of patients with TMD-related myalgia during six months after receiving BTX-A injections. The research question was: What are the outcomes in pain, quality of life and function of patients with TMD-related myalgia receiving BTX-A during 6 months? The hypothesis to be tested was that patients receiving a BTX-A injection due to TMD-related myalgia will have a reduction in pain and increase in quality of life and function after one, three- and six- months.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Masseter Myofascial Pain Relief Following an Intra-muscular Injection With Botulinum Toxin Type A.#1172892
- Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles#901154
- Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia#842382
- Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis#905398
- Phase IV Study On Muscle Activity Of Two Commercial Preparations Of Botulinum#1096888
Record · ID 878532
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive